BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 15867662)

  • 21. Computer-assisted teaching of epistaxis management: a Randomized Controlled Trial.
    Glicksman JT; Brandt MG; Moukarbel RV; Rotenberg B; Fung K
    Laryngoscope; 2009 Mar; 119(3):466-72. PubMed ID: 19235749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopically guided chitosan nasal packing for intractable epistaxis.
    Shikani AH; Chahine KA; Alqudah MA
    Am J Rhinol Allergy; 2011; 25(1):61-3. PubMed ID: 21711982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of FloSeal haemostatic agent in the management of epistaxis.
    Khan MK; Reda El Badawey M; Powell J; Idris M
    J Laryngol Otol; 2015 Apr; 129(4):353-7. PubMed ID: 25776997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis.
    Meric Teker A; Korkut AY; Kahya V; Gedikli O
    Eur Arch Otorhinolaryngol; 2010 Sep; 267(9):1377-81. PubMed ID: 20155359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of floseal hemostatic matrix for control of hemostasis during laparoscopic cholecystectomy for acute cholecystitis: a multicenter historical control group comparison (the GLA study gelatin matrix for acute cholecystitis).
    Sartelli M; Catena F; Biancafarina A; Tranà C; Piccardo A; Ceccarelli G; Tirone G; Agresta F; Di Giorgio A; Catani M; Tricarico F; Buonanno M; Piazza L
    J Laparoendosc Adv Surg Tech A; 2014 Dec; 24(12):837-41. PubMed ID: 25025393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrin glue treatment for epistaxis.
    Vaiman M; Segal S; Eviatar E
    Rhinology; 2002 Jun; 40(2):88-91. PubMed ID: 12092000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective surgicel packing for the treatment of posterior epistaxis.
    Bhatnagar RK; Berry S
    Ear Nose Throat J; 2004 Sep; 83(9):633-4. PubMed ID: 15529650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant.
    Raga F; Sanz-Cortes M; Bonilla F; Casañ EM; Bonilla-Musoles F
    Fertil Steril; 2009 Jul; 92(1):356-60. PubMed ID: 19423098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of FloSeal as a potential intracavitary hemostatic agent.
    Klemcke HG
    J Trauma; 2006 Feb; 60(2):385-9. PubMed ID: 16508500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal packing after septoplasty: a randomized comparison of packing versus no packing in 88 patients.
    Awan MS; Iqbal M
    Ear Nose Throat J; 2008 Nov; 87(11):624-7. PubMed ID: 19006062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive treatment of intractable posterior epistaxis with hot-water irrigation.
    Schlegel-Wagner C; Siekmann U; Linder T
    Rhinology; 2006 Mar; 44(1):90-3. PubMed ID: 16550958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on epistaxis.
    Douglas R; Wormald PJ
    Curr Opin Otolaryngol Head Neck Surg; 2007 Jun; 15(3):180-3. PubMed ID: 17483687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of FloSeal hemostatic matrix in a patient with severe postpartum hemorrhage.
    Lemmer R; Albrech M; Bauer G
    J Obstet Gynaecol Res; 2012 Feb; 38(2):435-7. PubMed ID: 22229547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemostatic agent microporous polysaccharide hemospheres (MPH) does not affect healing or intact sinus mucosa.
    Antisdel JL; Janney CG; Long JP; Sindwani R
    Laryngoscope; 2008 Jul; 118(7):1265-9. PubMed ID: 18438268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the use of Floseal haemostatic matrix in the treatment of epistaxis: a prospective, control-matched longitudinal study.
    Lau AS; Upile NS; Lazarova L; Swift AC
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2579-84. PubMed ID: 26920703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial.
    Zahed R; Moharamzadeh P; Alizadeharasi S; Ghasemi A; Saeedi M
    Am J Emerg Med; 2013 Sep; 31(9):1389-92. PubMed ID: 23911102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model.
    Ereth MH; Schaff M; Ericson EF; Wetjen NM; Nuttall GA; Oliver WC
    Neurosurgery; 2008 Oct; 63(4 Suppl 2):369-72; discussion 372. PubMed ID: 18981845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: a randomized controlled trial.
    Kim HJ; Fraser MR; Kahn B; Lyman S; Figgie MP
    J Bone Joint Surg Am; 2012 Jul; 94(13):1160-5. PubMed ID: 22623075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stapled technique for acute thrombosed hemorrhoids: a randomized, controlled trial with long-term results.
    Wong JC; Chung CC; Yau KK; Cheung HY; Wong DC; Chan OC; Li MK
    Dis Colon Rectum; 2008 Apr; 51(4):397-403. PubMed ID: 18097723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gelatin matrix treatment of complex renal injuries in a porcine model.
    Hick EJ; Morey AF; Harris RA; Morris MS
    J Urol; 2005 May; 173(5):1801-4. PubMed ID: 15821591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.